Valiant Laboratories peers

Companies like Valiant Laboratorieslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VALIANTLAB₹125.82

Valiant Laboratories Limited

· Pharma & Health
₹ CrorePeersALBERTDAVDHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹683 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VALIANTLAB
FY26
ALBERTDAVD
FY26
HALEOSLABS
FY26
ZIMLAB
FY26
Peer
Average
Valuation — at last close
P/E——◆ 25.33×118.71×72.02×
P/B2.20×◆ 1.13×2.05×2.55×1.91× +15%
EV/EBITDA108.79×38.64×◆ 12.56×27.83×26.35× +313%
Market Cap₹683 Cr₹441 Cr₹439 Cr₹756 Cr₹545 Cr +25%
Growth
Revenue CAGR 3Y—-0.78%◆ 1.89%-2.06%-0.32%
Revenue CAGR 5Y—◆ 6.16%4.68%—5.42%
Net Income CAGR 3Y——◆ 16.09%-37.95%-10.93%
Revenue YoY (latest Q)◆ 146.22%43.60%-11.59%31.25%21.09% +593%
Net Income YoY (latest Q)◆ 1058.93%303.12%-58.00%-114.25%43.62% +2327%
Profitability
EBITDA Margin2.69%1.64%◆ 13.38%8.02%7.68% -65%
Net Income Margin-1.38%-0.45%◆ 5.33%1.56%2.15% -164%
Return on Common Equity-1.20%-0.38%◆ 8.44%2.13%3.40% -135%
Return on Capital Employed0.10%-1.06%◆ 10.70%3.06%4.23% -98%
Return on Assets-0.76%-0.29%◆ 4.22%1.15%1.69% -145%
Credit & Quality
Total Debt/Equity0.14×◆ 0.07×0.47×0.42×0.32× -56%
Interest Coverage0.18×-1.63×◆ 4.53×0.76×1.22× -85%
Scale — latest FY
Revenue / Total Income₹237 Cr₹334 Cr₹334 Cr₹374 Cr₹347 Cr -32%
Net Income−₹3.3 Cr−₹1.5 Cr₹17.8 Cr₹5.8 Cr₹7.4 Cr -144%
Total Assets₹464 Cr₹519 Cr₹454 Cr₹539 Cr₹504 Cr -8%
EPS₹-0.51₹-2.62₹57.26₹1.19₹18.61 -103%
Book Value per Share₹57.24₹686.04₹706.34₹55.36₹482.58 -88%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.